Loading provider…
Loading provider…
Internal Medicine Physician in Providence, RI
NPI: 1275520678Primary Practice Location
THE MIRIAM HOSPITAL
164 Summit Ave, Providence, RI
Primary Employer
Brown Health Medical Group Primary Care
brownhealth.org
HQ Phone
Get MD David's Phone Numberphone_androidMobile
Get MD David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardRI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 245 | 429 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 168 | 182 |
| 3 | 99497Advance care planning by the physician or other qualified health care professional | 111 | 114 |
| 4 | G0008Administration of influenza virus vaccine | 30 | 30 |
| 5 | 90662Vaccine for influenza for injection into muscle | 25 | 25 |
Authors: Lavery, Lawrence, Fulmer, James, Shebetka, Karry Ann, Regulski, Matthew, Vayser, Dean, Fried, David, Kashefsky, Howard, Owings, Tammy M, Nadarajah, Janaki, Hesp, Zoe
Journal: Wounds
Publication Date: 2018-06-29
Authors: Geoffrey Gorse, Ann Falsey, John Ervin, Dennis Morrison
Journal: Vaccine
Publication Date: 2013-09-20
The efficacy and safety of Grafix(®) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial.
Authors: Lawrence Lavery, James Fulmer, Karry Shebetka, Matthew Regulski, Dean Vayser, David Fried, Howard Kashefsky, Tammy Owings, Janaki Nadarajah
Publication Date: 2014-03-14
Lead Sponsor: Vaxcyte, Inc.
Intervention / Treatment: BIOLOGICAL: 24 valent pneumococcal conjugate vaccine, BIOLOGICAL: 20 valent pneumococcal conjugate vaccine
Lead Sponsor: Satsuma Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Dihydroergotamine
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Tirzepatide